The Medcomm is reputed journal publishes research related to Biochemistry (medical) (Q1); Cell Biology (Q1); Drug Discovery (Q1); Genetics (Q1); Genetics (clinical) (Q1); Immunology and Allergy (Q1); Oncology (Q1). The ISSN of the journal is .
Through this web page, researchers can check the indexing, publication fee, journal quartile, and journal aim & scope.
| Journal Title | MedComm |
|---|---|
| Publisher | John Wiley and Sons Inc |
| Publication Country | United States |
| ISSN | 26882663 |
| Publication Area | Biochemistry, Genetics and Molecular Biology; Medicine; Pharmacology, Toxicology and Pharmaceutics |
| Publication Language | ENG |
| Review Process | Anonymous peer review |
| Scopus Indexed | Yes |
The Impact Factor of Medcomm in 2026 is 14.1.
The Medcomm is ranked in Q1.
The Medcomm is indexed in: DOAJ, Web of Science.
There is a fee to publish in the Medcomm. The publication fee is 3850 USD; 2810 GBP; 3360 EUR.
The journal also offers a fee waiver policy.
The Medcomm takes an average of 10 weeks to publish research papers.
The official website of the journal is https://onlinelibrary.wiley.com/journal/26882663.
Please visit only official website of the journal to submit research papers.